叶青, 蔡均均, 闫俊卿, 吕蓉. L3-PMI在乙肝肝硬化相关慢加急性肝衰竭患者预后评估中的作用. 世界华人消化杂志 2021; 29(20): 1167-1173 [DOI: 10.11569/wcjd.v29.i20.1167]
Reader's ID:
03656608
Submitted on:
November 02, 2021, 07:56
Reader Expertise:
Reader’s expertise on the topic of the manuscript
Conflicts-of-Interest Statement:
Does the reader have a conflict of interest?
Reader Comment Standards for Published Articles:
Scientific Quality:
The overall quality of the manuscript, based on the above-listed criteria, should be evaluated and classified according to the following five categories
Language Quality:
Language quality (style, grammar, and spelling) should be evaluated and classified according to the following five categories.
Reader Comments:
近年来，肌肉减少症与终末期肝病患者预后的关系逐渐受到国内外学者的广泛关注。肌肉减少症的诊断主要取决于对肌肉质量、力量和功能的评估，但目前还缺乏统一的检测方法和诊断标准。L3-PMI因测量方法简便易行, 在评估肌肉含量中日益受到关注。本文作者以L3-PMI为切入点，评估评估乙肝肝硬化相关慢加急性肝衰竭患者的L3-PMI与临床指标的关系及其在预后评估中的作用。其研究表明，L3-PMI用于识别肌肉减少症简便易行，对临床医生评估乙肝肝硬化相关慢加急性肝衰竭患者的预后有一定的临床应用价值。